NYSE : COPL
-$0.01 (-0.1%)
| Source | Headline |
|---|---|
|
Copley Acquisition Corp (NYSE: COPL) and Ignite Proteomics Announce Business Combination Agreement to Advance Precision Oncology
HONG KONG, June 11, 2026 (GLOBE NEWSWIRE) -- Copley Acquisition Corp (NYSE: COPL) (“Copley”), a special purpose acquisition company and Ignite Proteomics, LLC (“Ignite” or “Ignite Proteomics”), a leader in pathway-level protein analytics to guide precision oncology, announced today that they have entered into a definitive business combination agreement (“BCA”). globenewswire.com - 2026-06-11 06:00:00 |